| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/22/2007 | WO2007021004A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021003A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020898A1 Gene involved in silicon uptake and use thereof |
| 02/22/2007 | WO2007020880A1 Method of producing lymphocytes |
| 02/22/2007 | WO2007020873A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/22/2007 | WO2007020786A1 Gene transfer method specific to trophectodermal cell |
| 02/22/2007 | WO2007020655A1 Establishment of a human embryonic stem cell line using mammalian cells |
| 02/22/2007 | WO2007020611A2 Adult human neural stem/progenitor cells from the olfactory epithelium and olfactory lamina propria, isolation method, proliferation and differentiation in serum free culture medium and utilization for transplantation |
| 02/22/2007 | WO2007019858A2 Subtilases |
| 02/22/2007 | WO2007001895A3 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 02/22/2007 | WO2006135385A3 Antagonizing interleukin-21 receptor activity |
| 02/22/2007 | WO2006110843A3 Engineered deremal tissue particles and transplantation methods |
| 02/22/2007 | WO2006102559A3 Drought-resistant plants |
| 02/22/2007 | WO2006092650A3 A composition for creating an artificial bone -marrow like environment and use thereof |
| 02/22/2007 | WO2006084007A3 Novel gene underlying atherosclerosis locus i |
| 02/22/2007 | WO2006083671A3 Bacterial glycolipid activation of cd1d-restricted nkt cells |
| 02/22/2007 | WO2006071441A3 Antibodies directed to gpnmb and uses thereof |
| 02/22/2007 | WO2006068946A3 Enhancement of beta-carotene content in plants |
| 02/22/2007 | WO2006063302A3 Variants of glycogen synthase kinase 3 and uses thereof |
| 02/22/2007 | WO2006047673A3 Mammalian genes involved in infection |
| 02/22/2007 | WO2006044611A3 Neurotransmitter sensors and methods of using the same |
| 02/22/2007 | WO2005121338A9 Anti-perp antibody |
| 02/22/2007 | WO2005111060A3 Molecules involved in protein folding and methods op identifying them |
| 02/22/2007 | WO2005042719A3 Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents |
| 02/22/2007 | WO2004085616A3 Regulation of self-renewal in stem cells |
| 02/22/2007 | WO2004058800A3 Mammalian cell culture processes for protein production |
| 02/22/2007 | WO2004048543A3 Methods and compositions for controlling valency of phage display |
| 02/22/2007 | US20070044181 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| 02/22/2007 | US20070044178 AXMI-028 and AXMI-029, a family of novel delta-endotoxin genes and methods for their use |
| 02/22/2007 | US20070044177 Genetically engineered duckweed |
| 02/22/2007 | US20070044176 Nitrate transport components |
| 02/22/2007 | US20070044174 Vanillin production |
| 02/22/2007 | US20070044172 use of nucleotide sequences in the genetic-engineering of plants to display enhanced nitrogen assimilatory and utilization capacities, grow larger, more efficiently or rapidly, and/or have enriched nitrogen contents in vegetative and/or reproductive plant parts and/or increased biomass |
| 02/22/2007 | US20070044171 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 02/22/2007 | US20070044168 Transplantable tumor model |
| 02/22/2007 | US20070044167 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070044165 Non-human mammal model comprising heterologous nucleated cells - use for screening compounds |
| 02/22/2007 | US20070044162 Transgenic rat as animal model for human huntingdon's disease |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070042494 Heterologous retroviral packaging system |
| 02/22/2007 | US20070042492 Amino acid sequences for transferring substances of interest from outside medium to inside of cells, specifically cell nuclei; useful for enhancing delivery of drugs into cytoplasm and/or the cell nucleus from the host organism being treated |
| 02/22/2007 | US20070042491 Amplification of cell populations from embryonic stem cells |
| 02/22/2007 | US20070042490 Apparatus and method for tissue engineering |
| 02/22/2007 | US20070042488 Cell spraying device, method and sprayed cell suspension |
| 02/22/2007 | US20070042483 Methods and device for adhesive control of internal cell organisation |
| 02/22/2007 | US20070042468 Interferon-like protein zcyto21 |
| 02/22/2007 | US20070042466 Il-1 related polypeptides |
| 02/22/2007 | US20070042464 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 02/22/2007 | US20070042462 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia |
| 02/22/2007 | US20070042372 Method for designing dna codes used as information carrier |
| 02/22/2007 | US20070042359 E-protein specific immunoglobulin for use in treatment and prevention of viral infection |
| 02/22/2007 | US20070042344 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 02/22/2007 | US20070042341 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells |
| 02/22/2007 | US20070042338 Enriched with oxygen and comprises base nutritive medium and liposomes comprising cholesterol; biopsies; freezing; drug screening |
| 02/22/2007 | US20070042017 Medical device with coating that promotes endothelial cell adherence and differentiation |
| 02/22/2007 | US20070042002 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070042001 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070041990 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/22/2007 | US20070041989 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/22/2007 | US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
| 02/22/2007 | US20070041982 ILT3 binding molecules and uses therefor |
| 02/22/2007 | US20070041980 CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/22/2007 | US20070041977 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/22/2007 | US20070041972 Antibodies and fusion proteins that include engineered constant regions |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041967 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 02/22/2007 | US20070041966 Polypeptides including modified constant regions |
| 02/22/2007 | US20070041965 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041960 Apparatus and methods for enzymatic debridement of skin lesions |
| 02/22/2007 | US20070041957 Stimulating formation of an inner ear sensory hair cell for treatment of sensorineuronal hearing loss; deafness |
| 02/22/2007 | US20070041955 Hedgehog signaling promotes the formation of three dimensional cartilage matrices |
| 02/22/2007 | US20070041954 Compositions of placentally-derived stem cells for the treatment of cancer |
| 02/22/2007 | US20070041953 Smooth Muscle Progenitor Cells |
| 02/22/2007 | US20070041951 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof |
| 02/22/2007 | US20070041948 Method for culturing and proliferating hematopoietic stem cells and progenitor cells using human endometrial cells |
| 02/22/2007 | US20070041946 Serotype of adenovirus and uses thereof |
| 02/22/2007 | US20070041945 Novel method for down-regulation of amyloid |
| 02/22/2007 | US20070041943 Expression of virus entry inhibitors and recombinant AAV thereof |
| 02/22/2007 | US20070041937 G-csf derivative for inducing immunological tolerance |
| 02/22/2007 | US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | CA2656705A1 Influenza recombinant subunit vaccine |
| 02/22/2007 | CA2619763A1 Fas binding antibodies |
| 02/22/2007 | CA2619725A1 Single chain antibodies against beta-amyloid peptide |
| 02/22/2007 | CA2619693A1 Implantable cartilaginous tissue repair device |
| 02/22/2007 | CA2619577A1 Gene disruptions, compositions and methods relating thereto |
| 02/22/2007 | CA2619243A1 Topographical templating of polymeric materials using cellular morphology |
| 02/22/2007 | CA2619048A1 Vegf-activated fas ligands |
| 02/22/2007 | CA2608833A1 Establishment of a human embryonic stem cell line using mammalian cells |
| 02/22/2007 | CA2607965A1 Pharmacokinetic-based culture system with biological barriers |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754786A2 Herbicide resistant products based on structure-based method |